Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology

Disease prevention

Home » Health and medicine » Disease prevention

Codagenix Inc. Announces Award of $1M US Army Contract for Continued Development of Contemporary, Balanced Dengue Vaccine

Farmingdale, New York, April 24, 2019 – Codagenix, Inc., announces today the awarding of a U.S. Department of Defense (DOD) Phase II SBIR contract to continue the development and testing of a live attenuated...

Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic

Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications

Sustainable Squalene Replacement Needed for Pharma EMERYVILLE, Calif. and SEATTLE, Feb. 12, 2019 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), and IDRI (Infectious Disease Research Institute), are pleased to...

Oxitec Transitioning Friendly™ Self-limiting Mosquitoes to 2nd Generation Technology Platform, Paving Way to New Scalability, Performance and Cost Breakthroughs

Oxitec

Oxitec to Develop 2nd Friendly™ Mosquito Strain Designed to Combat Malaria-Spreading Mosquitoes

Inovio

Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies

Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges

Genetically modified mosquitoes may be best weapon for curbing disease transmission

Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes

GenScript Supports the Development of a Novel HIV Vaccine

Oxitec Launches Field Trial in Brazil for Next Generation Addition to Friendly™ Mosquitoes Platform

NIH Awards Grant to Lumen Bioscience for Cost-Effective Oral Malaria Vaccine

fight cancer

Five amazing ways redesigning biological cells could help us fight cancer

Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS

EPA opens public comment period for Oxitec’s Experimental Use Permit application for Friendly™ Mosquitoes in Florida Keys